Cough News and Research

RSS

Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension

Pfizer Inc. announced that Revatio (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17 years old with pulmonary arterial hypertension. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease.

5 May 2011

FDA releases final guidance to firms that market OTC drug products

The U.S. Food and Drug Administration today released its final guidance to firms that manufacture, market, or distribute over-the-counter liquid drug products packaged with cups, droppers, syringes, and spoons to measure and dispense the doses of medication.

5 May 2011

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

Tulsa Shock guard Andrea Riley and Basketball Hall of Famer Bob Lanier teamed up with NBA Cares and the Society for Adolescent Health and Medicine today to bring Vaccines for Teens to the Tulsa community.

5 May 2011

Survey reports 60% of workers feel guilty if they call in sick

Sniff, sniff. Achoo! With cold and flu season in full swing, these sounds are likely to be heard around the office. A new CareerBuilder Canada survey finds that 66 per cent of workers typically go to work when they are sick.

29 Apr 2011

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Affymax, Inc. and Takeda Pharmaceutical Company Limited, today announced results of additional analyses from two Phase 3 studies of the investigational agent, peginesatide in chronic renal failure patients on dialysis with anemia.

29 Apr 2011

Longer looks: Autism researcher's legacy; methadone for prisoners

Andrew Wakefield has become one of the most reviled doctors of his generation, blamed directly and indirectly, depending on the accuser, for irresponsibly starting a panic with tragic repercussions: vaccination rates so low that childhood diseases once all but eradicated here —whooping cough and measles, among them — have re-emerged, endangering young lives. And yet here he was in Texas, post-career-apocalypse, calmly discussing his work, and a crowd of around 250 people showed up to listen.

29 Apr 2011

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.

28 Apr 2011

ASTRO develops new thoracic radiotherapy guideline

The American Society for Radiation Oncology has developed a guideline for the use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused by advanced lung cancer. The guideline will be published in Practical Radiation Oncology, an official journal of ASTRO.

28 Apr 2011

Northwestern Asthma-COPD Program with palliative medicine can enhance patient care

When faced with a long-term illness, patients often retreat or are left feeling hopeless, a response that can negatively impact one's prognosis and impair their quality of life. When coping measures are offered however, the opposite can hold true.

27 Apr 2011

Scientists identify key enzyme that destroys lung tissue in TB

Scientists have identified a key enzyme responsible for destroying lung tissue in tuberculosis, they report today in the Journal of Clinical Investigation. Drugs that inhibit this enzyme are already available, meaning that the finding could lead quickly to new treatments.

26 Apr 2011

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

AstraZeneca today announced that the orphan drug vandetanib is now available to U.S. patients for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.

25 Apr 2011

Ahead of Immunization Week, WHO calls for countries to come together to control measles outbreak in Europe

WHO is urging countries in Europe to join together to help control the measles outbreak that has grown to more than 6,500 cases in 33 countries and the potential for worsening outbreaks "in the days ahead as people travel during the Easter holidays," U.N. News Centre reports.

25 Apr 2011

Californians for Patient Care reminds parents about affordable infants' immunizations

In advance of National Infant Immunization Week, observed April 23-30, Californians for Patient Care reminds parents there are affordable immunizations available for their infants in their communities.

25 Apr 2011

Rite Aid reduces price of whooping cough vaccine for children in California

Parents in California can now get their children vaccinated against whooping cough at more than 500 Rite Aid pharmacies for the newly lowered price of $57.99. By July 1, when a new state law takes effect requiring proof of vaccination for all students entering grades 7 through 12, nearly all of the approximately 600 California Rite Aid locations will be able to vaccinate walk-in patients or by appointment.

22 Apr 2011

Researchers discover new compound to fight against shingles

Researchers at the University of Georgia and Yale University have discovered a compound with the potential to be more effective than existing agents in treating the very painful blisters known as shingles-a condition that affects up to 30 percent of Americans, mostly elderly, and for which no specific treatment exists.

22 Apr 2011

Merck and Sanofi Pasteur commence Phase III trial of pediatric hexavalent combination vaccine

Merck and Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today the initiation of a Phase III clinical program to evaluate the safety and immunogenicity of an investigational pediatric hexavalent combination vaccine.

21 Apr 2011

Measles alert issued in Tasmania

Tasmanian health authorities have issued an alert over a measles case. They issued a statement revealing that a woman who travelled to Devonport on the Spirit of Tasmania on Monday has been diagnosed with the infectious disease. She was one of four people to contract measles while on board an Air Asia flight from Kuala Lumpur to Melbourne.

17 Apr 2011

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.

11 Apr 2011

Gilenya can reduce risk of disability progression in patients with RRMS

A new analysis demonstrated that Gilenya reduced the risk of disability progression in patients with relapsing-remitting multiple sclerosis, regardless of treatment history. This analysis of the phase III two-year FREEDOMS study is one of 11 abstracts on Gilenya being presented at the 63rd annual meeting of the American Academy of Neurology.

11 Apr 2011

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

AstraZeneca today announced that the U.S. Food and Drug Administration approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.

7 Apr 2011

Cough News and Research

Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension

FDA releases final guidance to firms that market OTC drug products

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

Survey reports 60% of workers feel guilty if they call in sick

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Longer looks: Autism researcher's legacy; methadone for prisoners

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

ASTRO develops new thoracic radiotherapy guideline

Northwestern Asthma-COPD Program with palliative medicine can enhance patient care

Scientists identify key enzyme that destroys lung tissue in TB

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

Ahead of Immunization Week, WHO calls for countries to come together to control measles outbreak in Europe

Californians for Patient Care reminds parents about affordable infants' immunizations

Rite Aid reduces price of whooping cough vaccine for children in California

Researchers discover new compound to fight against shingles

Merck and Sanofi Pasteur commence Phase III trial of pediatric hexavalent combination vaccine

Measles alert issued in Tasmania

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Gilenya can reduce risk of disability progression in patients with RRMS

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News